Lansoprazole
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Norfolk and Norwich University Hospitals NHS Foundation Trust
Overview
Lansoprazole is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Lansoprazole clinical trials
Explore related
Medical disclaimer. This page summarizes research about Lansoprazole for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.